Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02593825 · ClinicalTrials.gov registry record · NA
Efficacy of the START-Play Program for Infants With Neuromotor Disorders
A NA study, sponsored by Duquesne University.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT02593825 is a NA study that has completed, run by Duquesne University. The registered enrollment target is 134 participants.
The verdict
NCT02593825, a NA study, has completed, sponsored by Duquesne University.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
The purpose of this project is to evaluate the efficacy of Sitting Together And Reaching To Play (START-Play), an intervention designed to target sitting, reaching, and motor-based problem solving to improve development and readiness to learn in infants with motor delays or dysfunction. There is limited research examining the efficacy of early physical intervention on infants with neuromotor dysfunction. In addition, most early motor interventions have not been directly linked to learning, despite the research demonstrating an association between motor activity and cognitive skills. START-Play specifically targets motor skills that lead to greater physical exploration, which has been associated with improved problem solving and global development. A randomized controlled trial of START-Play will be conducted across four states to investigate the impact of the intervention on changes over time in sitting and reaching, subsequent changes in global cognitive development, and the mediating influences of motor skill changes and problem solving. The research team will conduct a randomized controlled trial to evaluate the impact of START-Play on motor development, motor problem solving, global development including cognitive problem solving of infants with neuromotor delay and dysfunction. Infants will experience either the intervention or services as usual for 3 months, with following testing at three time points up until 9 months post intervention. The researchers will determine whether the intervention leads to improved sitting and reaching, which leads to improved motor-based problem solving, which leads to improved global development and problem solving.
Interventions
- BEHAVIORAL START-Play intervention
- BEHAVIORAL Business as usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2016-01 |
| Est. Completion | 2022-06-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02593825
The ClinicalTrials.gov registry entry for NCT02593825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duquesne University, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which START-Play intervention is the first listed.
NCT02593825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02593825 about?
NCT02593825 is a clinical study titled "Efficacy of the START-Play Program for Infants With Neuromotor Disorders". The purpose of this project is to evaluate the efficacy of Sitting Together And Reaching To Play (START-Play), an intervention designed to target sitting, reaching, and motor-based problem solving to improve development and readiness to learn in infants with motor delays or dysfunction. There is lim...
What is the current status of trial NCT02593825?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2016-01. Estimated completion is 2022-06-12.
What interventions are being tested in trial NCT02593825?
The interventions under investigation include: START-Play intervention (BEHAVIORAL), Business as usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT02593825?
This trial is sponsored by Duquesne University, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.